Trial Profile
Efficacy and safety of rifabutin-based high dose proton pump inhibitor, and amoxicillin triple regimen for treatment of Helicobacter-pylori-infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Rifabutin (Primary) ; Amoxicillin; Lansoprazole
- Indications Helicobacter pylori infections
- Focus Adverse reactions; Therapeutic Use
- 16 Dec 2015 New trial record